Your shopping cart is currently empty

CYP19A1-IN-1 (Compound 9) is an inhibitor of CYP19A1 with an IC50 value of 271 nM. It functions by binding to CYP19A1, thereby inhibiting its activity in converting androgens to estrogens. CYP19A1-IN-1 is applicable in research related to estrogen-dependent breast cancer and other sex hormone-related conditions.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | CYP19A1-IN-1 (Compound 9) is an inhibitor of CYP19A1 with an IC50 value of 271 nM. It functions by binding to CYP19A1, thereby inhibiting its activity in converting androgens to estrogens. CYP19A1-IN-1 is applicable in research related to estrogen-dependent breast cancer and other sex hormone-related conditions. |
| Molecular Weight | 393.823 |
| Formula | C21H16ClN3O3 |
| Cas No. | 889959-22-2 |
| Smiles | O=C1OC=2C=CC(Cl)=CC2C=C1C(=O)NC(C3=CC=C(C=C3)N4C=NC=C4)C |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.